BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  BioGaia Signs Major Distribution And License Agreements With Partner In Japan

  December 5, 2016

   · 

  2 min read
• Drug Development

  Poxel SAS Release: Ability To Delay Type 2 Diabetes Disease Progression By Preserving Beta Cell Mass Observed In New Imeglimin Data

  December 5, 2016

   · 

  4 min read
• Dr. Reddy’s Laboratories Ltd. Announces The Launch Of Nystatin And Triamcinolone Acetonide Cream, USP In The U.S. Market

  December 5, 2016

   · 

  2 min read
• Drug Development

  Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared To Rituxan

  December 5, 2016

   · 

  16 min read
• Drug Development

  Incyte Release: Pooled Analysis Of Five-Year Data From Two Phase 3 Studies Further Supports Overall Survival Advantage Observed In Patients With Myelofibrosis Treated With Jakafi (Ruxolitinib)

  December 5, 2016

   · 

  8 min read
• Drug Development

  Acetylon Presents Early Phase 1a/1b Results For Citarinostat (ACY-241) In Combination With Pomalyst And Dexamethasone Showing Promising Treatment Responses In Relapsed Or Relapsed-And-Refractory Multiple Myeloma

  December 5, 2016

   · 

  5 min read
• Drug Development

  Alexion Release: New Data From ALXN1210 Dose-Escalation Study Presented At American Society of Hematology Show Rapid And Sustained Reductions In LDH In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

  December 5, 2016

   · 

  14 min read
• Drug Development

  Acceleron Pharma And Celgene Announce Updated Results From Ongoing Phase 2 Studies Of Luspatercept In Myelodysplastic Syndromes At The 58th Annual Meeting Of American Society of Hematology

  December 5, 2016

   · 

  6 min read
• Drug Development

  Alnylam Reports Positive Interim Clinical Results For Fitusiran From Ongoing Phase 2 Open Label Extension Study In Patients With Hemophilia A Or B Without Inhibitors

  December 5, 2016

   · 

  12 min read
• Business

  Vizient, Inc. Joins Momentum To Measure And Improve Progress Toward Safer Chemicals In The Healthcare Industry

  December 5, 2016

   · 

  3 min read